Close

YTHDC1

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

YTHDC1 (YTH Domain Containing 1) is a Protein Coding gene. Among its related pathways are Chromatin Regulation Acetylation. Gene Ontology (GO) annotations related to this gene include N6-methyladenosine-containing RNA binding.
  • CAR Vector Products

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-0320ZP2365 Anti-YTHDC1 (E4I9E) h(CD28-CD3ζ) CAR, pCDCAR1 Human E4I9E Rabbit scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP2366 Anti-YTHDC1 (E4I9E) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human E4I9E Rabbit scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP2367 Anti-YTHDC1 (E2P2I) h(CD28-CD3ζ) CAR, pCDCAR1 Human E2P2I Rabbit scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP2368 Anti-YTHDC1 (E2P2I) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human E2P2I Rabbit scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP2369 Anti-YTHDC1 (CB2370) h(CD28-CD3ζ) CAR, pCDCAR1 Human CB2370 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP2370 Anti-YTHDC1 (CB2370) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human CB2370 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP2371 Anti-YTHDC1 (CB2372) h(CD28-CD3ζ) CAR, pCDCAR1 Human CB2372 Human scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP2372 Anti-YTHDC1 (CB2372) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human CB2372 Human scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.